ALIMTA [clinicaltrials_resource:cd6e661f62f8aec0d43e17267797866e]
ALIMTA (Pemetrexed) in Patients With Locally Advanced or Metastatic Cancer [clinicaltrials:NCT00034463]A Trial of ALIMTA (Pemetrexed) Plus Irinotecan in Patients Who Have Been Previously Treated For Metastatic Colorectal Cancer. [clinicaltrials:NCT00034502]A Phase 2 Trial of ALIMTA (Pemetrexed) Plus Gemcitabine in Locally Advanced or Metastatic Transitional Cell Carcinoma of the Urothelium [clinicaltrials:NCT00034593]A Phase 2 Trial of ALIMTA (LY231514, Pemetrexed) Plus Oxaliplatin Administered Every 21 Days for First-Line Treatment of Patients With Advanced Colorectal Cancer. [clinicaltrials:NCT00034619]A Phase 3 Trial of ALIMTA (LY231514, Pemetrexed) Plus GEMZAR Versus GEMZAR in Patients With Unresectable or Metastatic Cancer of the Pancreas. [clinicaltrials:NCT00035035]ALIMTA Plus Carboplatin as Front-Line Chemotherapy for Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer: A Phase 2 Clinical Trial. [clinicaltrials:NCT00051493]ALIMTA(Pemetrexed)/Cisplatin and ALIMTA(Pemetrexed)/Carboplatin in Extensive Stage Small Cell Lung Cancer. [clinicaltrials:NCT00051506]
intervention [clinicaltrials_vocabulary:intervention]
ALIMTA [clinicaltrials_resource:cd6e661f62f8aec0d43e17267797866e]
Bio2RDF identifier
cd6e661f62f8aec0d43e17267797866e
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:cd6e661f62f8aec0d43e17267797866e
intervention name [clinicaltrials_vocabulary:intervention-name]
identifier
clinicaltrials_resource:cd6e661f62f8aec0d43e17267797866e
title
ALIMTA
@en
type
label
ALIMTA [clinicaltrials_resource:cd6e661f62f8aec0d43e17267797866e]
@en